Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MDX2001 |
Synonyms | |
Therapy Description |
Limited information is currently available on MDX2001, a putative tetraspecific antibody targeting two T-cell receptors and two tumor antigens (Jun 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MDX2001 | MDX-2001|MDX 2001 | Limited information is currently available on MDX2001, a putative tetraspecific antibody targeting two T-cell receptors and two tumor antigens (Jun 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06239194 | Phase Ib/II | MDX2001 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | Recruiting | USA | 0 |